Non-alcoholic fatty liver disease (NAFLD), characterized by excessive lipid accumulation in the liver without significant alcohol intake or other specific liver damage factors, has become an emerging global health problem. The current global incidence of NAFLD is 20%–33%, and this number is rapidly increasing along with the prevalence of obesity (1-3).